These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12476093)

  • 21. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
    Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia.
    Srivastava SK; Sternberg P
    Retina; 2002 Oct; 22(5):669-71. PubMed ID: 12441742
    [No Abstract]   [Full Text] [Related]  

  • 23. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Isola V; Pece A; Brancato R
    Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
    [No Abstract]   [Full Text] [Related]  

  • 26. Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration.
    Schmidt-Erfurth U; Wolf S;
    Br J Ophthalmol; 2008 Dec; 92(12):1628-35. PubMed ID: 18772178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Back pain after photodynamic therapy with verteporfin.
    Pece A; Vadalà M; Manzi R; Calori G
    Am J Ophthalmol; 2006 Mar; 141(3):593-4. PubMed ID: 16490525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Verteporfin infusion-associated pain.
    Borodoker N; Spaide RF; Maranan L; Murray J; Freund KB; Slakter JS; Sorenson JA; Yannuzzi LA; Guyer DR; Fisher YL
    Am J Ophthalmol; 2002 Feb; 133(2):211-4. PubMed ID: 11812424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hot spots after photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Battaglia Parodi M; Da Pozzo S
    Retina; 2002 Oct; 22(5):671-3. PubMed ID: 12441743
    [No Abstract]   [Full Text] [Related]  

  • 30. Verteporfin ocular photodynamic therapy.
    Bakri SJ; Kaiser PK
    Expert Opin Pharmacother; 2004 Jan; 5(1):195-203. PubMed ID: 14680447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.
    Aquaron R; Forzano O; Murati JL; Fayet G; Aquaron C; Ridings B
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):925-30. PubMed ID: 12699252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
    Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
    Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.
    Larsen M; Schmidt-Erfurth U; Lanzetta P; Wolf S; Simader C; Tokaji E; Pilz S; Weisberger A;
    Ophthalmology; 2012 May; 119(5):992-1000. PubMed ID: 22424834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS; Solomon SD; Bressler NM; Bressler SB
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study.
    Kaiser PK; Boyer DS; Cruess AF; Slakter JS; Pilz S; Weisberger A;
    Ophthalmology; 2012 May; 119(5):1001-10. PubMed ID: 22444829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verteporfin: new indication. In certain age-related macular degeneration: too little evidence.
    Prescrire Int; 2004 Feb; 13(69):7-9. PubMed ID: 15055207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: from clinical trials to clinical practice.
    Sickenberg M
    Semin Ophthalmol; 2001 Dec; 16(4):207-12. PubMed ID: 15513442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.